Description
Generic Name:
EMTAF PrEP contains Emtricitabine and Tenofovir Alafenamide.
Composition:
Each EMTAF PrEP Tablet comprises:
- Emtricitabine (200 mg)
- Tenofovir Alafenamide (25 mg)
Indication:
EMTAF PrEP is indicated for Pre-Exposure Prophylaxis (PrEP) to reduce the risk of HIV-1 infection in high-risk individuals when used in combination with safer sex practices.
Storage Instructions:
- Store at room temperature (25°C) in a dry place.
- Keep away from direct sunlight and moisture.
- Keep out of reach of children.
Uses of the Medicine:
- HIV prevention in high-risk individuals.
- Helps reduce the risk of HIV transmission when taken regularly.
- Used in combination with other preventative measures (e.g., condoms, regular testing).
Benefits of the Medicine:
- Reduces the risk of acquiring HIV-1 when taken daily.
- Improved safety profile compared to older PrEP formulations.
- Better kidney and bone safety than Tenofovir Disoproxil Fumarate-based PrEP.
- Convenient once-daily dosing.
Side Effects:
- Common side effects include:
- Nausea
- Diarrhea
- Headache
- Fatigue
- Abdominal pain
Serious Side Effects Include:
- Lactic acidosis (muscle pain, trouble breathing, weakness)
- Liver toxicity (yellowing of skin/eyes, dark urine, loss of appetite)
- Kidney problems (changes in urination, swelling in feet or hands)
- Bone loss or osteoporosis
How to Use the Medicine:
- Take one tablet daily at the same time each day.
- Can be taken with or without food.
- Swallow whole with water; do not chew or crush.
- Adherence is essential for maximum effectiveness.
How the Medicine Works:
EMTAF PrEP contains two nucleoside reverse transcriptase inhibitors (NRTIs):
Emtricitabine and Tenofovir Alafenamide prevent HIV from replicating in the body by inhibiting reverse transcriptase, a key enzyme in the virus’s replication process.
This stops HIV from establishing a permanent infection in high-risk individuals.
What If You Forget to Take the Medicine?
- Take the missed dose as soon as you remember.
- If it’s almost time for the next dose, skip the missed dose.
- Do not take two doses at once to make up for a missed one.
Quick Tips:
- Take EMTAF PrEP daily for full protection.
- Regular HIV testing is required while on PrEP.
- EMTAF PrEP is not a cure for HIV and does not protect against other STIs.
- Discuss with a healthcare provider before starting if you have kidney or liver conditions.
Safety Advice
Alcohol
Caution is advised when consuming alcohol with EMTAF Tablet. Please consult your doctor for guidance.
Pregnancy
EMTAF Tablet is unsafe to use during pregnancy due to potential harm to the developing baby. It may only be prescribed in life-threatening situations where benefits outweigh the risks. Please consult your doctor.
Breastfeeding
There is insufficient information on the use of EMTAF Tablet while breastfeeding. Please consult your doctor before use.
Driving
It is uncertain whether EMTAF Tablet affects your ability to drive. Avoid driving if you experience drowsiness, dizziness, or reduced alertness.
Kidney
Limited data is available on the safety of EMTAF Tablet in patients with kidney disease. Dose adjustments may be necessary. Please consult your doctor.
Liver
EMTAF Tablet should be used with caution in patients with liver disease. Dose adjustments may be required based on the severity of the condition. Please consult your doctor.
FAQs:
Q: Can EMTAF PrEP cure HIV?
A: No, EMTAF PrEP does not cure HIV but helps prevent infection.
Q: How long does it take for EMTAF PrEP to be effective?
A: It takes at least 7 days to provide maximum protection for receptive anal sex and up to 21 days for vaginal sex.
Q: Can I stop taking EMTAF PrEP if I no longer think I’m at risk?
A: Speak to your doctor before stopping, as consistent use is necessary for full protection.
Related Lab Tests:
- HIV test (before and during PrEP use)
- Kidney function test
- Hepatitis B screening
- Bone density test (if required)
Reviews
There are no reviews yet.